The DOI matches its Crossref record; 258 of the 258 references it cites were found in a registry or an index.
The cannabinoid system and pain
Open accessAbstract
Abstract Chronic pain states are highly prevalent and yet poorly controlled by currently available analgesics, representing an enormous clinical, societal, and economic burden. Existing pain medications have significant limitations and adverse effects including tolerance, dependence, gastrointestinal dysfunction, cognitive impairment, and a narrow therapeutic window, making the search for novel analgesics ever more important. In this article, we review the role of an important endogenous pain control system, the endocannabinoid (EC) system, in the sensory, emotional, and cognitive aspects of pain. Herein, we briefly cover the discovery of the EC system and its role in pain processing pathways, before concentrating on three areas of current major interest in EC pain research; 1. Pharmacological enhancement of endocannabinoid activity (via blockade of EC metabolism or allosteric modulation of CB1 receptors); 2. The EC System and stress‐induced modulation of pain; and 3. The EC system & medial prefrontal cortex (mPFC) dysfunction in pain states. Whilst we focus predominantly on the preclinical data, we also include extensive discussion of recent clinical failures of endocannabinoid‐related therapies, the future potential of these approaches, and important directions for future research on the EC system and pain. This article is part of the Special Issue entitled “A New Dawn in Cannabinoid Neurobiology”. HighlightsThe endocannabinoid (EC) system is a key endogenous pain control system.Elevating or enhancing EC signalling is antinociceptive in preclinical models.Recent clinical failures suggest study limitations and gaps in basic knowledge.Future directions and strategies to improve clinical translation are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · cited 2×
“It was not until the 1990s that the molecular targets mediating its effects were discovered (the cannabinoid receptors CB1 & CB2 - Devane et al., 1988; Munro et al., 1993), and the mechanisms and sites of action elucidated (Gregg et al.”
Central sensitization: a generator of pain hypersensitivity by central neural plasticity
Latremoliere, A., & Woolf, C. J. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2009.06.012 · Cited by 3,913
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 1×
“It was not until the 1990s that the molecular targets mediating its effects were discovered (the cannabinoid receptors CB1 & CB2 - Devane et al., 1988; Munro et al., 1993), and the mechanisms and sites of action elucidated (Gregg et al., 2012; Herkenham et al., 1990; Hohmann et al., 2005; Martin et…”
The Economic Costs of Pain in the United States
Gaskin, D. J., & Richard, P. (2012) · The Journal of Pain · doi:10.1016/j.jpain.2012.03.009 · Cited by 2,359
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321 · cited 2×
“, 1993), and the mechanisms and sites of action elucidated (Gregg et al., 2012; Herkenham et al., 1990; Hohmann et al., 2005; Martin et al., 1999; Walker and Hohmann, 2005; Walker and Huang, 2002).”
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125 · cited 1×
“Fatty-acid amide hydrolase (FAAH) was identified as the major enzyme degrading fatty-acid amides which bind to cannabinoid receptors, such as AEA, but also the related compounds oleoylethanolamine (OEA) and palmitoylethanolamine (PEA) which do not (Cravatt et al., 1996).”
The induction of pain: an integrative review
Millan, M. J. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00048-3 · Cited by 1,774
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728 · cited 1×
“The EC system has subsequently emerged as a likely candidate, based on the evidence for an important role of CB1 receptors in the infralimbic mPFC in fear extinction (Lin et al., 2009; Marsicano et al., 2002).”
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,587
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529
A second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Chronic back pain is associated with decreased prefrontal and thalamic gray matter density
Apkarian, A. V., Sosa, Y., Sonty, S., Levy, R. M., Harden, R. N., Parrish, T. B., & Gitelman, D. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2541-04.2004 · Cited by 1,434
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031914-122957 · Cited by 1,388 · cited 2×
“nificant limitations including constipation, tolerance and dependence which have contributed to an epidemic of addiction and drug-related deaths in the US in recent years (Kolodny et al., 2015).”
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373 · cited 1×
“Monoacyglycerol lipase (MAGL) was identified as the major enzyme responsible for terminating 2-AG signalling (Dinh et al., 2002, 2004), and though other enzymes do contribute to 2-AG metabolism in vivo (Blankman et al., 2007; Marrs et al., 2010), ~85% of hydrolytic activity in brain can be…”
Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310
Cortical pathways to the mammalian amygdala
McDonald, A. J. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00003-3 · Cited by 1,303
Modulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
The Kyoto protocol of IASP Basic Pain Terminology ☆
Loeser, J. D., & Treede, R.-D. (2008) · Pain · doi:10.1016/j.pain.2008.04.025 · Cited by 1,240
Prefrontal cortex in the rat: Projections to subcortical autonomic, motor, and limbic centers
Gabbott, P. L. A., Warner, T. A., Jays, P. R. L., Salway, P., & Busby, S. J. (2005) · Journal of Comparative Neurology · doi:10.1002/cne.20738 · Cited by 1,227
Sierra-Mercado, D., Padilla-Coreano, N., & Quirk, G. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.184 · Cited by 1,190 · cited 1×
“Decreased infralimbic activity has been implicated in extinction deficits (Chang and Maren, 2010; Hefner et al., 2008; Kim et al., 2010; Sierra-Mercado et al., 2011).”
A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
Blankman, J. L., Simon, G. M., & Cravatt, B. F. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.006 · Cited by 1,177 · cited 2×
“, 2002, 2004), and though other enzymes do contribute to 2-AG metabolism in vivo (Blankman et al., 2007; Marrs et al., 2010), ~85% of hydrolytic activity in brain can be attributed to MAGL.”
The effect of pain on cognitive function: A review of clinical and preclinical research
Moriarty, O., McGuire, B. E., & Finn, D. P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.002 · Cited by 1,122
Self-citationControl of pain initiation by endogenous cannabinoids
Calignano, A., Rana, G. L., Giuffrida, A., & Piomelli, D. (1998) · Nature · doi:10.1038/28393 · Cited by 1,056
Pape, H.-C., & Pare, D. (2010) · Physiological Reviews · doi:10.1152/physrev.00037.2009 · Cited by 994
Marsicano, G., & Lutz, B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00847.x · Cited by 937
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
Long, J. Z., Li, W., Booker, L., Burston, J. J., Kinsey, S. G., Schlosburg, J. E., Pavón, F. J., Serrano, A. M., Selley, D. E., Parsons, L. H., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.129 · Cited by 934
Estimates of Pain Prevalence and Severity in Adults: United States, 2012
Nahin, R. L. (2015) · The Journal of Pain · doi:10.1016/j.jpain.2015.05.002 · Cited by 918 · cited 1×
“…functional antagonism of the brain EC system, resulting in profound downregulation and desensitization of CB1 receptors in nociception-associated regions, and a loss of analgesic phenotype (Chanda et al., 2010; Imperatore et al., 2015; Navia-Paldanius et al., 2015; Schlosburg et al., 2010).”
Fear and anxiety: divergent effects on human pain thresholds
Rhudy, J. L., & Meagher, M. W. (2000) · Pain · doi:10.1016/s0304-3959(99)00183-9 · Cited by 913
Towards a theory of chronic pain
Apkarian, A. V., Baliki, M. N., & Geha, P. Y. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.09.018 · Cited by 876 · cited 1×
“Whilst acute pain can be considered adaptive, chronic pain in the absence of injury, following its resolution, or following damage to the nervous system (neuropathic pain) is a pathological condition of enormous clinical, societal, and economic significance (Apkarian et al., 2009).”
Cannabinoid CB2 receptors: immunohistochemical localization in rat brain
Gong, J.-P., Onaivi, E. S., Ishiguro, H., Liu, Q.-R., Tagliaferro, P. A., Brusco, A., & Uhl, G. R. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.035 · Cited by 820
The effects of cannabinoids on the brain
Ameri, A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00087-2 · Cited by 812
An endocannabinoid mechanism for stress-induced analgesia
Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Michael Walker, J., Holmes, P. V., Crystal, J. D., et al. (2005) · Nature · doi:10.1038/nature03658 · Cited by 778
Self-citationHall, W., & Solowij, N. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05021-1 · Cited by 772
Understanding the co-occurrence of anxiety disorders and chronic pain: state-of-the-art
Asmundson, G. J. G., & Katz, J. (2009) · Depression and Anxiety · doi:10.1002/da.20600 · Cited by 756
Butler, R. K., & Finn, D. P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.003 · Cited by 714
Self-citationNeurobiological Interactions Between Stress and the Endocannabinoid System
Morena, M., Patel, S., Bains, J. S., & Hill, M. N. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.166 · Cited by 660
Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system
Schlosburg, J. E., Blankman, J. L., Long, J. Z., Nomura, D. K., Pan, B., Kinsey, S. G., Nguyen, P. T., Ramesh, D., Booker, L., Burston, J. J., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2616 · Cited by 641
Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens
Robbe, D., Kopf, M., Remaury, A., Bockaert, J., & Manzoni, O. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122149199 · Cited by 631
Multiple Functions of Endocannabinoid Signaling in the Brain
Katona, I., & Freund, T. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150420 · Cited by 630
Prefrontal control of fear: more than just extinction
Sotres-Bayon, F., & Quirk, G. J. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.02.005 · Cited by 625 · cited 2×
“Cortical control of amygdala function has been identified as a critical mechanism of fear extinction (Herry et al., 2010; Likhtik et al., 2005; Marek et al., 2013; Orsini and Maren, 2012; Pape and Pare, 2010; Sotres-Bayon and Quirk, 2010).”
The influence of negative emotions on pain: Behavioral effects and neural mechanisms
Wiech, K., & Tracey, I. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.05.059 · Cited by 614
The molecular dynamics of pain control
Hunt, S. P., & Mantyh, P. W. (2001) · Nature Reviews Neuroscience · doi:10.1038/35053509 · Cited by 610
Anandamide and vanilloid TRPV1 receptors
Ross, R. A. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705467 · Cited by 604
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease
Katona, I., & Freund, T. F. (2008) · Nature Medicine · doi:10.1038/nm.f.1869 · Cited by 579
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors
Agarwal, N., Pacher, P., Tegeder, I., Amaya, F., Constantin, C. E., Brenner, G. J., Rubino, T., Michalski, C. W., Marsicano, G., Monory, K., et al. (2007) · Nature Neuroscience · doi:10.1038/nn1916 · Cited by 571
Gulyas, A. I., Cravatt, B. F., Bracey, M. H., Dinh, T. P., Piomelli, D., Boscia, F., & Freund, T. F. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03428.x · Cited by 561 · cited 3×
“…whilst FAAH is found postsynaptically (Gulyas et al., 2004), in stark contrast to the established complementary post-synaptic position of the 2-AG synthesizing enzyme DAGLa (Gregg et al., 2012; Nyilas et al., 2009) and pre-synaptic position of MAGL (Gulyas et al., 2004; Horv ath et al., 2014).”
Chronic pain patients are impaired on an emotional decision-making task
Apkarian, V. A., Sosa, Y., Krauss, B. R., Thomas, S. P., Fredrickson, B. E., Levy, R. E., Harden, N. R., & Chialvo, D. R. (2004) · Pain · doi:10.1016/j.pain.2003.12.015 · Cited by 536
Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans
Gavva, N. R., Treanor, J. J. S., Garami, A., Fang, L., Surapaneni, S., Akrami, A., Alvarez, F., Bak, A., Darling, M., Gore, A., et al. (2008) · Pain · doi:10.1016/j.pain.2008.01.024 · Cited by 525
Long-range connectivity defines behavioral specificity of amygdala neurons
Senn, V., Wolff, S. B. E., Herry, C., Grenier, F., Ehrlich, I., Gründemann, J., Fadok, J. P., Müller, C., Letzkus, J. J., & Lüthi, A. (2014) · Neuron · doi:10.1016/j.neuron.2013.11.006 · Cited by 522
Cannabinoids go nuclear: evidence for activation of peroxisome proliferator‐activated receptors
O'Sullivan, S. E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707423 · Cited by 510
Pain modulation by release of the endogenous cannabinoid anandamide
Walker, J. M., Huang, S. M., Strangman, N. M., Tsou, K., & Sañudo-Peña, M. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12198 · Cited by 485
Neuronal circuits of fear extinction
Herry, C., Ferraguti, F., Singewald, N., Letzkus, J. J., Ehrlich, I., & Lüthi, A. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07101.x · Cited by 484
The Endocannabinoid System and Pain
Guindon, J., & Hohmann, A. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824660 · Cited by 476
Self-citationAn update on PPAR activation by cannabinoids
O'Sullivan, S. E. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13497 · Cited by 449
Allosteric Modulation of the Cannabinoid CB1 Receptor
Price, M. R., Baillie, G. L., Thomas, A., Stevenson, L. A., Easson, M., Goodwin, R., McLean, A., McIntosh, L., Goodwin, G., Walker, G., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.016162 · Cited by 443
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors
Marrs, W. R., Blankman, J. L., Horne, E. A., Thomazeau, A., Lin, Y. H., Coy, J., Bodor, A. L., Muccioli, G. G., Hu, S. S.-J., Woodruff, G., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2601 · Cited by 441
Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain
Ahn, K., Johnson, D. S., Mileni, M., Beidler, D., Long, J. Z., McKinney, M. K., Weerapana, E., Sadagopan, N., Liimatta, M., Smith, S. E., et al. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.02.013 · Cited by 439
Neural and cellular mechanisms of fear and extinction memory formation
Orsini, C. A., & Maren, S. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.014 · Cited by 429
Guindon, J., & Hohmann, A. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707531 · Cited by 423
Self-citationMorphological and functional reorganization of rat medial prefrontal cortex in neuropathic pain
Metz, A. E., Yau, H.-J., Centeno, M. V., Apkarian, A. V., & Martina, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809897106 · Cited by 407
Neugebauer, V. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-662-46450-2_13 · Cited by 399
Self-citationLong, J. Z., Nomura, D. K., Vann, R. E., Walentiny, D. M., Booker, L., Jin, X., Burston, J. J., Sim-Selley, L. J., Lichtman, A. H., Wiley, J. L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909411106 · Cited by 391
Cognitive Impairment in Pain through Amygdala-Driven Prefrontal Cortical Deactivation
Ji, G., Sun, H., Fu, Y., Li, Z., Pais-Vieira, M., Galhardo, V., & Neugebauer, V. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0225-10.2010 · Cited by 387
Self-citationSelective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
Ghilardi, J. R., Röhrich, H., Lindsay, T. H., Sevcik, M. A., Schwei, M. J., Kubota, K., Halvorson, K. G., Poblete, J., Chaplan, S. R., Dubin, A. E., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3815-04.2005 · Cited by 384
Stress-induced analgesia: adaptive pain suppression
Amit, Z., & Galina, Z. H. (1986) · Physiological Reviews · doi:10.1152/physrev.1986.66.4.1091 · Cited by 378
Huggins, J. P., Smart, T. S., Langman, S., Taylor, L., & Young, T. (2012) · Pain · doi:10.1016/j.pain.2012.04.020 · Cited by 375 · cited 2×
“However, despite being well-tolerated and producing significant elevations in peripheral blood levels of AEA, PF-04,457,845 failed to produce significant analgesia in a Phase II trial in late-stage osteoarthritis (OA) patients (Huggins et al., 2012).”
Gonsiorek, W., Lunn, C., Fan, X., Narula, S., Lundell, D., & Hipkin, R. W. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26516-0 · Cited by 369
Egertov�, M., & Elphick, M. R. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000626)422:2<159::aid-cne1>3.0.co;2-1 · Cited by 364
Hill, M. N., Patel, S., Carrier, E. J., Rademacher, D. J., Ormerod, B. K., Hillard, C. J., & Gorzalka, B. B. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300601 · Cited by 363
Prefrontal Control of the Amygdala
Likhtik, E., Pelletier, J. G., Paz, R., & Paré, D. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2314-05.2005 · Cited by 361
Egertová, M., Cravatt, B. F., & Elphick, M. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00145-3 · Cited by 347
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism
Clapper, J. R., Moreno-Sanz, G., Russo, R., Guijarro, A., Vacondio, F., Duranti, A., Tontini, A., Sanchini, S., Sciolino, N. R., Spradley, J. M., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2632 · Cited by 346 · cited 4×
“Both brain impermeant (Clapper et al., 2010) and brain permeant inhibitors of FAAH have been shown to suppress inflammatory pain induced by formalin, carrageenan, and Complete Freund's Adjuvant (CFA) (for review, see Guindon and Hohmann, 2009).”
InfluentialSelf-citationPain and Emotion: Effects of Affective Picture Modulation
Meagher, M. W., Arnau, R. C., & Rhudy, J. L. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200101000-00010 · Cited by 342
Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain
Kinsey, S. G., Long, J. Z., O’Neal, S. T., Abdullah, R. A., Poklis, J. L., Boger, D. L., Cravatt, B. F., & Lichtman, A. H. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155465 · Cited by 330
Identification of intracellular carriers for the endocannabinoid anandamide
Kaczocha, M., Glaser, S. T., & Deutsch, D. G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901515106 · Cited by 326
Toward a Mechanism-Based Approach to Pain Diagnosis
Vardeh, D., Mannion, R. J., & Woolf, C. J. (2016) · The Journal of Pain · doi:10.1016/j.jpain.2016.03.001 · Cited by 319
Jennings, E. M., Okine, B. N., Roche, M., & Finn, D. P. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.06.003 · Cited by 318
Self-citationRapid Broad-Spectrum Analgesia through Activation of Peroxisome Proliferator-Activated Receptor-α
LoVerme, J., Russo, R., La Rana, G., Fu, J., Farthing, J., Mattace-Raso, G., Meli, R., Hohmann, A., Calignano, A., & Piomelli, D. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111385 · Cited by 316
Self-citationThe amygdala and medial prefrontal cortex: partners in the fear circuit
Marek, R., Strobel, C., Bredy, T. W., & Sah, P. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.248575 · Cited by 304 · cited 2×
“Cortical control of amygdala function has been identified as a critical mechanism of fear extinction (Herry et al., 2010; Likhtik et al., 2005; Marek et al., 2013; Orsini and Maren, 2012; Pape and Pare, 2010; Sotres-Bayon and Quirk, 2010).”
The Palmitoylethanolamide Family: A New Class of Anti-Inflammatory Agents ?
Lambert, D., Vandevoorde, S., Jonsson, K.-O., & Fowler, C. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023370707 · Cited by 299
Maione, S., Bisogno, T., de Novellis, V., Palazzo, E., Cristino, L., Valenti, M., Petrosino, S., Guglielmotti, V., Rossi, F., & Marzo, V. D. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093286 · Cited by 294
Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models
Jayamanne, A., Greenwood, R., Mitchell, V. A., Aslan, S., Piomelli, D., & Vaughan, C. W. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706510 · Cited by 287
Mayer, E. A., Berman, S., Suyenobu, B., Labus, J., Mandelkern, M. A., Naliboff, B. D., & Chang, L. (2005) · Pain · doi:10.1016/j.pain.2005.03.023 · Cited by 275
Antihyperalgesic effects of spinal cannabinoids
Richardson, J. D., Aanonsen, L., & Hargreaves, K. M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01621-x · Cited by 275
Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses
Busquets-Garcia, A., Puighermanal, E., Pastor, A., de la Torre, R., Maldonado, R., & Ozaita, A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.022 · Cited by 273
Molecular Components and Functions of the Endocannabinoid System in Mouse Prefrontal Cortex
Lafourcade, M., Elezgarai, I., Mato, S., Bakiri, Y., Grandes, P., & Manzoni, O. J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000709 · Cited by 249
Hefner, K., Whittle, N., Juhasz, J., Norcross, M., Karlsson, R.-M., Saksida, L. M., Bussey, T. J., Singewald, N., & Holmes, A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4904-07.2008 · Cited by 248
Affective pictures processing, attention, and pain tolerance
de Wied, M., & Verbaten, M. N. (2001) · Pain · doi:10.1016/s0304-3959(00)00400-0 · Cited by 248
Presynaptic Modulation by Endocannabinoids
Lovinger, D. M. (2008) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-74805-2_14 · Cited by 246
Rademacher, D. J., Meier, S. E., Shi, L., Vanessa Ho, W.-S., Jarrahian, A., & Hillard, C. J. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.012 · Cited by 233 · cited 1×
“Stress and fear have been shown to alter levels of endocannabinoids in these brain regions (Carrier et al., 2005; Gregg et al., 2012; Hill et al., 2005, 2013; Hohmann et al., 2005; Morena et al., 2015; Olango et al., 2012; Patel et al., 2005; Rademacher et al., 2008).”
The absolute configuration of δ1-tetrahydrocannabinol, the major active constituent of hashish.
Mechoulam, R., & Gaoni, Y. (1967) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)90646-4 · Cited by 231
Ahn, K., Smith, S. E., Liimatta, M. B., Beidler, D., Sadagopan, N., Dudley, D. T., Young, T., Wren, P., Zhang, Y., Swaney, S., et al. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.180257 · Cited by 230
Role of Prelimbic GABAergic Circuits in Sensory and Emotional Aspects of Neuropathic Pain
Zhang, Z., Gadotti, V. M., Chen, L., Souza, I. A., Stemkowski, P. L., & Zamponi, G. W. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.001 · Cited by 229
Dinh, T. P., Kathuria, S., & Piomelli, D. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002071 · Cited by 229
Chanda, P. K., Gao, Y., Mark, L., Btesh, J., Strassle, B. W., Lu, P., Piesla, M. J., Zhang, M.-Y., Bingham, B., Uveges, A., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.068304 · Cited by 226
Infralimbic cortex activation increases c-fos expression in intercalated neurons of the amygdala
Berretta, S., Pantazopoulos, H., Caldera, M., Pantazopoulos, P., & Paré, D. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.020 · Cited by 223
Hill, M. N., Kumar, S. A., Filipski, S. B., Iverson, M., Stuhr, K. L., Keith, J. M., Cravatt, B. F., Hillard, C. J., Chattarji, S., & McEwen, B. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.90 · Cited by 222
mGluR5 Has a Critical Role in Inhibitory Learning
Xu, J., Zhu, Y., Contractor, A., & Heinemann, S. F. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5716-08.2009 · Cited by 221
Wang, G.-Q., Cen, C., Li, C., Cao, S., Wang, N., Zhou, Z., Liu, X.-M., Xu, Y., Tian, N.-X., Zhang, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms8660 · Cited by 207
The Role of the Endocannabinoid System in Pain
Woodhams, S. G., Sagar, D. R., Burston, J. J., & Chapman, V. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-662-46450-2_7 · Cited by 202
Self-citationMaione, S., De Petrocellis, L., de Novellis, V, Moriello, A. S., Petrosino, S., Palazzo, E., Rossi, F. S., Woodward, D. F., & Di Marzo, V (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707145 · Cited by 196
Swanson, D. M., Dubin, A. E., Shah, C., Nasser, N., Chang, L., Dax, S. L., Jetter, M., Breitenbucher, J. G., Liu, C., Mazur, C., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0495071 · Cited by 185
Spinal Endocannabinoids and CB 1 Receptors Mediate C-Fiber–Induced Heterosynaptic Pain Sensitization
Pernía-Andrade, A. J., Kato, A., Witschi, R., Nyilas, R., Katona, I., Freund, T. F., Watanabe, M., Filitz, J., Koppert, W., Schüttler, J., et al. (2009) · Science · doi:10.1126/science.1171870 · Cited by 184
Self-citationRusso, R., LoVerme, J., La Rana, G., Compton, T. R., Parrott, J., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Calignano, A., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.119941 · Cited by 182
Anti-inflammatory lipoxin A 4 is an endogenous allosteric enhancer of CB 1 cannabinoid receptor
Pamplona, F. A., Ferreira, J., Menezes de Lima, O., Duarte, F. S., Bento, A. F., Forner, S., Villarinho, J. G., Bellocchio, L., Wotjak, C. T., Lerner, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202906109 · Cited by 179
Techniques for Assessing Knee Joint Pain in Arthritis
Neugebauer, V., Han, J. S., Adwanikar, H., Fu, Y., & Ji, G. (2007) · Molecular Pain · doi:10.1186/1744-8069-3-8 · Cited by 179
Self-citationRodriguez, A. L., Grier, M. D., Jones, C. K., Herman, E. J., Kane, A. S., Smith, R. L., Williams, R., Zhou, Y., Marlo, J. E., Days, E. L., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.067207 · Cited by 178
Ignatowska-Jankowska, B. M., Baillie, G. L., Kinsey, S., Crowe, M., Ghosh, S., Owens, R. A., Damaj, I. M., Poklis, J., Wiley, J. L., Zanda, M., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.148 · Cited by 177
Cannabinoid Mechanisms of Pain Suppression
Walker, J. M., & Hohmann, A. G. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_17 · Cited by 176
Self-citationWalker, J. M., & Huang, S. M. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00252-8 · Cited by 176
The Endogenous Opioid System and Clinical Pain Management
Holden, J. E., Jeong, Y., & Forrest, J. M. (2005) · AACN Clinical Issues: Advanced Practice in Acute and Critical Care · doi:10.1097/00044067-200507000-00003 · Cited by 174
Little, J. P., & Carter, A. G. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2385-13.2013 · Cited by 172
Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight
Di Marzo, V. (2011) · Nature Neuroscience · doi:10.1038/nn.2720 · Cited by 170
Holt, S., Comelli, F., Costa, B., & Fowler, C. J. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706348 · Cited by 168 · cited 2×
“Systemic FAAH inhibition is anti-inflammatory via CB2 in the carrageenan model in mice (Holt et al., 2005), and produces CB1-mediated antinociception in the CFA model in rats (Wilson et al., 2005).”
Pain-related deactivation of medial prefrontal cortical neurons involves mGluR1 and GABA A receptors
Ji, G., & Neugebauer, V. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00461.2011 · Cited by 168
Self-citationInhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms
Chang, L., Luo, L., Palmer, J. A., Sutton, S., Wilson, S. J., Barbier, A. J., Breitenbucher, J. G., Chaplan, S. R., & Webb, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706773 · Cited by 166
Martin, W. J., Coffin, P. O., Attias, E., Balinsky, M., Tsou, K., & Walker, J. M. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01368-7 · Cited by 164
Patel, S., Cravatt, B. F., & Hillard, C. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300535 · Cited by 164
Guindon, J., Lai, Y., Takacs, S. M., Bradshaw, H. B., & Hohmann, A. G. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.013 · Cited by 160
Self-citationAnalgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain
Jhaveri, M. D., Richardson, D., Kendall, D. A., Barrett, D. A., & Chapman, V. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3326-06.2006 · Cited by 159
Hohmann, A. G. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00154-8 · Cited by 159
Self-citationEvaluation of NHS Carbamates as a Potent and Selective Class of Endocannabinoid Hydrolase Inhibitors
Niphakis, M. J., Cognetta, A. B., Chang, J. W., Buczynski, M. W., Parsons, L. H., Byrne, F., Burston, J. J., Chapman, V., & Cravatt, B. F. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400116z · Cited by 157
Self-citationThe complications of promiscuity: endocannabinoid action and metabolism
Alexander, S. P. H., & Kendall, D. A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707456 · Cited by 157
Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms
Chang, L., Luo, L., Palmer, J. A., Sutton, S., Wilson, S. J., Barbier, A. J., Breitenbucher, J. G., Chaplan, S. R., & Webb, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706699 · Cited by 155
Cannabinoid Tolerance and Dependence
Lichtman, A. H., & Martin, B. R. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_24 · Cited by 154
COX2 in CNS neural cells mediates mechanical inflammatory pain hypersensitivity in mice
Vardeh, D., Wang, D., Costigan, M., Lazarus, M., Saper, C. B., Woolf, C. J., FitzGerald, G. A., & Samad, T. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37098 · Cited by 152
Endocannabinoid tone versus constitutive activity of cannabinoid receptors
Howlett, A. C., Reggio, P. H., Childers, S. R., Hampson, R. E., Ulloa, N. M., & Deutsch, D. G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01364.x · Cited by 146
Cannabinoid modulation of executive functions
Pattij, T., Wiskerke, J., & Schoffelmeer, A. N. M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.099 · Cited by 145
Slivicki, R. A., Xu, Z., Kulkarni, P. M., Pertwee, R. G., Mackie, K., Thakur, G. A., & Hohmann, A. G. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.06.032 · Cited by 144
Self-citationGuindon, J., Guijarro, A. I., Piomelli, D., & Hohmann, A. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01192.x · Cited by 143
Self-citationLomazzo, E., Bîndilă, L., Remmers, F., Lerner, R., Schwitter, C., Hoheisel, U., & Lutz, B. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.198 · Cited by 143
Inhibition of Fatty Acid Binding Proteins Elevates Brain Anandamide Levels and Produces Analgesia
Kaczocha, M., Rebecchi, M. J., Ralph, B. P., Teng, Y.-H. G., Berger, W. T., Galbavy, W., Elmes, M. W., Glaser, S. T., Wang, L., Rizzo, R. C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094200 · Cited by 142 · cited 1×
“Fatty acid binding proteins have been strongly implicated (e.g. Kaczocha et al., 2009, 2015, 2014), but their roles have yet to be full elucidated.”
Jhaveri, M. D., Richardson, D. S., Robinson, I., Garle, M. J., Patel, A., Sun, Y., Sagar, D. R., Bennett, A. J., Alexander, S. P. H., Kendall, D. A., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.04.018 · Cited by 139
Self-citationDifferent Fear States Engage Distinct Networks within the Intercalated Cell Clusters of the Amygdala
Busti, D., Geracitano, R., Whittle, N., Dalezios, Y., Mańko, M., Kaufmann, W. A., Sätzler, K., Singewald, N., Capogna, M., & Ferraguti, F. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6100-10.2011 · Cited by 138
Hong, S. K., Fan, J., Kemmerer, E. S., Evans, S. J., Li, Y., & Wiley, J. W. (2008) · Gut · doi:10.1136/gut.2008.157594 · Cited by 134
Lee, S.-H., Ledri, M., Toth, B., Marchionni, I., Henstridge, C. M., Dudok, B., Kenesei, K., Barna, L., Szabo, S. I., Renkecz, T., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4112-14.2015 · Cited by 133
Physiological identification and infralimbic responsiveness of rat intercalated amygdala neurons
Amir, A., Amano, T., & Paré, D. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00136.2011 · Cited by 131
Schlosburg, J. E., Carlson, B. L. A., Ramesh, D., Abdullah, R. A., Long, J. Z., Cravatt, B. F., & Lichtman, A. H. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9110-7 · Cited by 129
Kiritoshi, T., Ji, G., & Neugebauer, V. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4047-15.2016 · Cited by 129
Self-citationIgnatowska‐Jankowska, B. M., Ghosh, S., Crowe, M. S., Kinsey, S. G., Niphakis, M. J., Abdullah, R. A., Tao, Q., O' Neal, S. T., Walentiny, D. M., Wiley, J. L., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12298 · Cited by 128
Harnessing the anti-inflammatory potential of palmitoylethanolamide
Alhouayek, M., & Muccioli, G. G. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.007 · Cited by 128
Hermanson, D. J., Gamble‐George, J., Marnett, L. J., & Patel, S. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.006 · Cited by 128
Ghosh, S., Wise, L. E., Chen, Y., Gujjar, R., Mahadevan, A., Cravatt, B. F., & Lichtman, A. H. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.06.020 · Cited by 127
Li, G. L., Winter, H. R., Arends, R., Jay, G. W., Le, V., Young, T., & Huggins, J. P. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04137.x · Cited by 127
O’Mahony, C. M., Clarke, G. A., Gibney, S. M., Dinan, T. G., & Cryan, J. F. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.11.012 · Cited by 127
Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
Hermanson, D. J., Hartley, N. D., Gamble-George, J., Brown, N., Shonesy, B. C., Kingsley, P. J., Colbran, R. J., Reese, J., Marnett, L. J., & Patel, S. (2013) · Nature Neuroscience · doi:10.1038/nn.3480 · Cited by 126 · cited 1×
“In addition, substrate-specific inhibitors of COX2 have been developed which selectively block the hydrolysis of AEA, but spare other molecules (Hermanson et al., 2013, 2014).”
Cognitive impairment of prefrontal-dependent decision-making in rats after the onset of chronic pain
Pais-Vieira, M., Sousa, M. M., Lima, D., & Galhardo, V. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.04.011 · Cited by 122
Nyilas, R., Dudok, B., Urbán, G. M., Mackie, K., Watanabe, M., Cravatt, B. F., Freund, T. F., & Katona, I. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5102-07.2008 · Cited by 119
The role of prefrontal cortex CB1 receptors in the modulation of fear memory
Lin, H.-C., Mao, S.-C., Su, C.-L., & Gean, P.-W. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn075 · Cited by 119
Kinsey, S. G., Long, J. Z., Cravatt, B. F., & Lichtman, A. H. (2010) · The Journal of Pain · doi:10.1016/j.jpain.2010.04.001 · Cited by 118 · cited 12×
“Both CB1 and CB2 have been implicated in the antinociceptive effects of FAAH inhibition in this model (Ahn et al., 2011; Jayamanne et al., 2006), and a CB2 component is likely of increased importance in models of inflammatory pain due to potential involvement of CB2-expressing peripheral immune cells and glial cells o…”
InfluentialCheriyan, J., Kaushik, M. K., Ferreira, A. N., & Sheets, P. L. (2016) · eNeuro · doi:10.1523/eneuro.0002-16.2016 · Cited by 117
Booker, L., Kinsey, S. G., Abdullah, R. A., Blankman, J. L., Long, J. Z., Ezzili, C., Boger, D. L., Cravatt, B. F., & Lichtman, A. H. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01445.x · Cited by 116 · cited 1×
“Indeed, several distinct classes of FAAH inhibitors reduce nociceptive behaviour following hindpaw administration of LPS, and a detailed investigation of the mechanism implicates both CB1 and CB2, but not TRPV1, PPARa, or m-opioid receptors (Booker et al., 2012).”
Suplita, R. L., Farthing, J. N., Gutierrez, T., & Hohmann, A. G. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.07.007 · Cited by 115
Self-citationEnantiospecific Allosteric Modulation of Cannabinoid 1 Receptor
Laprairie, R. B., Kulkarni, P. M., Deschamps, J. R., Kelly, M. E. M., Janero, D. R., Cascio, M. G., Stevenson, L., Pertwee, R. G., Kenakin, T., Denovan‐Wright, E. M., et al. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00310 · Cited by 114
Valverde, O., Ledent, C. A., Beslot, F., Parmentier, M., & Roques, B. P. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00929.x · Cited by 113
Guindon, J., Desroches, J., & Beaulieu, P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706990 · Cited by 113
Ligand- and Heterodimer-Directed Signaling of the CB1 Cannabinoid Receptor
Hudson, B. D., Hébert, T. E., & Kelly, M. E. M. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.060251 · Cited by 112
Distribution of mGluR1α and mGluR5 immunolabeling in primate prefrontal cortex
Muly, E. C., Maddox, M., & Smith, Y. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10937 · Cited by 110
Dynamic Regulation of the Endocannabinoid System: Implications for Analgesia
Sagar, D. R., Gaw, A. G., Okine, B. N., Woodhams, S. G., Wong, A., Kendall, D. A., & Chapman, V. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-59 · Cited by 110
Self-citationMemory for Fear Extinction Requires mGluR5-Mediated Activation of Infralimbic Neurons
Fontanez-Nuin, D. E., Santini, E., Quirk, G. J., & Porter, J. T. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhq147 · Cited by 110
King, A. R., Duranti, A., Tontini, A., Rivara, S., Rosengarth, A., Clapper, J. R., Astarita, G., Geaga, J. A., Luecke, H., Mor, M., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.10.017 · Cited by 108
Neurobiology of Stress-Induced Hyperalgesia
Olango, W. M., & Finn, D. P. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_302 · Cited by 106
Self-citationA Molecular Basis of Analgesic Tolerance to Cannabinoids
Tappe‐Theodor, A., Agarwal, N., Katona, I., Rubino, T., Martini, L., Swiercz, J. M., Mackie, K., Monyer, H., Parolaro, D., Whistler, J. L., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5648-06.2007 · Cited by 106
Olango, W., Roche, M., Ford, G., Harhen, B., & Finn, D. P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01478.x · Cited by 105
Self-citationThe contribution of cyclooxygenase‐2 to endocannabinoid metabolism and action
Fowler, C. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707379 · Cited by 104
Lack of Medial Prefrontal Cortex Activation Underlies the Immediate Extinction Deficit
Kim, S. C., Jo, Y. S., Kim, I. H., Kim, H., & Choi, J.-S. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4145-09.2010 · Cited by 104
Finn, D. P. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.05.011 · Cited by 101
Self-citationImperatore, R., Morello, G., Luongo, L., Taschler, U., Romano, R., Gregorio, D. D., Belardo, C., Maione, S., Marzo, V. D., & Cristino, L. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13267 · Cited by 100
Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia
Nyilas, R., Gregg, L. C., Mackie, K., Watanabe, M., Zimmer, A., Hohmann, A. G., & Katona, I. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06751.x · Cited by 100
Self-citationLack of selectivity of URB602 for 2‐oleoylglycerol compared to anandamide hydrolysis in vitro
Vandevoorde, S., Jonsson, K., Labar, G., Persson, E., Lambert, D. M., & Fowler, C. J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706971 · Cited by 97
Clinical correlates of stress-induced analgesia: Evidence from pharmacological studies
Ford, G. K., & Finn, D. P. (2008) · Pain · doi:10.1016/j.pain.2008.09.023 · Cited by 95
Self-citationKinsey, S. G., Nomura, D. K., O’Neal, S. T., Long, J. Z., Mahadevan, A., Cravatt, B. F., Grider, J. R., & Lichtman, A. H. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.175778 · Cited by 94
Selective Monoacylglycerol Lipase Inhibitors: Antinociceptive versus Cannabimimetic Effects in Mice
Ignatowska-Jankowska, B. M., Wilkerson, J. L., Mustafa, M. A., Abdullah, R. A., Niphakis, M. J., Wiley, J. L., Cravatt, B. F., & Lichtman, A. H. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.222315 · Cited by 93
Medial prefrontal cortical innervation of the intercalated nuclear region of the amygdala
Pinard, C. R., Mascagni, F., & McDonald, A. J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.036 · Cited by 90
de Novellis, V., Vita, D., Gatta, L., Luongo, L., Bellini, G., De Chiaro, M., Marabese, I., Siniscalco, D., Boccella, S., Piscitelli, F., et al. (2011) · Molecular Pain · doi:10.1186/1744-8069-7-7 · Cited by 90 · cited 2×
“A significant supraspinal component to these effects has been described via microinjection of AA-5-HT into the PAG, resulting in CB1-, and TRPV1-dependent analgesia, and a restoration of the excitationinhibition balance in prefrontal cortex (de Novellis et al., 2008; de Novellis et al., 2011).”
Sagar, D. R., Kendall, D. A., & Chapman, V. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.335 · Cited by 90
Self-citationCardoso-Cruz, H., Sousa, M., Vieira, J. B., Lima, D., & Galhardo, V. (2013) · Pain · doi:10.1016/j.pain.2013.07.020 · Cited by 90
Guindon, J., & Beaulieu, P. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.12.002 · Cited by 90
Recent Advances in the Pharmacological Management of Pain
Guindon, J., Walczak, J., & Beaulieu, P. (2007) · Drugs · doi:10.2165/00003495-200767150-00002 · Cited by 90
Kaur, R., Sidhu, P., & Singh, S. (2016) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.189661 · Cited by 89
Gregg, L. C., Jung, K., Spradley, J. M., Nyilas, R., Suplita, R. L., Zimmer, A., Watanabe, M., Mackie, K., Katona, I., Piomelli, D., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0013-12.2012 · Cited by 89
Self-citationNoise Stress and Human Pain Thresholds: Divergent Effects in Men and Women
Rhud, J. L., & Meagher, M. W. (2001) · Journal of Pain · doi:10.1054/jpai.2000.19947 · Cited by 88
Khurana, L., Mackie, K., Piomelli, D., & Kendall, D. A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.018 · Cited by 87
Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia
Connell, K., Bolton, N., Olsen, D., Piomelli, D., & Hohmann, A. G. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.008 · Cited by 85
Self-citationSuplita, R. L., Gutierrez, T., Fegley, D., Piomelli, D., & Hohmann, A. G. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.10.007 · Cited by 84
Self-citationMoalem‐Taylor, G., Li, M., Allbutt, H. N., Wu, A., & Tracey, D. J. (2011) · Molecular Pain · doi:10.1186/1744-8069-7-1 · Cited by 84
Dynamic changes to the endocannabinoid system in models of chronic pain
Sagar, D. R., Burston, J. J., Woodhams, S. G., & Chapman, V. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0390 · Cited by 84
Self-citationRoche, M., O'Connor, E., Diskin, C., & Finn, D. P. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05861.x · Cited by 83
Self-citationBurke, N. N., Hayes, E., Calpin, P., Kerr, D. M., Moriarty, O., Finn, D. P., & Roche, M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.10.030 · Cited by 83
Self-citationKhasabova, I. A., Chandiramani, A., Harding-Rose, C., Simone, D. A., & Seybold, V. S. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.03.007 · Cited by 81
Endocannabinoids and Mental Disorders
Rubino, T., Zamberletti, E., & Parolaro, D. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_9 · Cited by 80
Alkaitis, M. S., Solórzano, C., Landry, R. P., Piomelli, D., DeLeo, J. A., & Romero-Sandoval, E. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010891 · Cited by 79
Wilkerson, J. L., Ghosh, S., Mustafa, M., Abdullah, R. A., Niphakis, M. J., Cabrera, R., Maldonado, R. L., Cravatt, B. F., & Lichtman, A. H. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.11.015 · Cited by 78
Sun, H., & Neugebauer, V. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00762.2010 · Cited by 77
Self-citationButler, R. K., Rea, K., Lang, Y., Gavin, A. M., & Finn, D. P. (2008) · Pain · doi:10.1016/j.pain.2008.10.002 · Cited by 76
Self-citationJi, G., & Neugebauer, V. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12432 · Cited by 76
Self-citationRea, K., Olango, W. M., Okine, B. N., Madasu, M. K., McGuire, I. C., Coyle, K., Harhen, B., Roche, M., & Finn, D. P. (2013) · Pain · doi:10.1016/j.pain.2013.09.012 · Cited by 76
Self-citation
Cited by
Cannabinoid Ligands Targeting TRP Channels
Muller, C., Morales, P., & Reggio, P. H. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00487 · Cited by 567
Cannabinoids and Pain: New Insights From Old Molecules
Vučković, S., Srebro, D., Vujović, K. S., Vučetić, Č., & Prostran, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01259 · Cited by 376
A neuronal circuit for activating descending modulation of neuropathic pain
Huang, J., Gadotti, V. M., Chen, L., Souza, I. A., Huang, S., Wang, D., Ramakrishnan, C., Deisseroth, K., Zhang, Z., & Zamponi, G. W. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0481-5 · Cited by 329
Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies
Finn, D. P., Haroutounian, S., Hohmann, A. G., Krane, E., Soliman, N., & Rice, A. S. C. (2021) · Pain · doi:10.1097/j.pain.0000000000002268 · Cited by 254
Self-citationGoods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183
Metadata
- Authors
- Woodhams, S. G., Chapman, V., Finn, D. P., Hohmann, A. G., & Neugebauer, V.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 124
- Pages
- 105-120
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2626577148
- Cited by
- 267
- References
- 258
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.